April 19, 2023 15:28 (London Time)

Inhibikase Therapeutics

Youtube Subscribe

Sector: Biotechnology

Ticker: IKT

Sentiment: 0.7424

MarketCap: 16,676,379

High: 0.58 Low: 0.56

Open: 0.57 Close: 0.58 Change: 0.01

Our AI found 13 flaws in Inhibikase Therapeutics.

How much time have you spent trying to decide whether investing in Inhibikase Therapeutics? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Inhibikase Therapeutics are: …

Concept Map

Semantic Network

Stock Summary

Inhibikase Therapeutics, Inc. develops therapeutics for Parkinson's disease and related disorders. Its lead product candidate is IkT-148009, a small molecule Abelson tyrosine kinase inhibitor. IkT.

Today's Summary

Inhibikase Therapeutics has a one year low of $0.44 and one year high of $1.34. Several large investors have recently bought and sold shares. Inhibikase Therapeutics Inc (IKT) Stock Price Today, News, Quotes, FAQs and Fundamentals StockTwits Logo Join the Conversation! Build your trading network Follow your favorite assets Link Your Portfolio and become verified Sign Up Log In Log In to become verified.

Today's News

Stock Profile

"Inhibikase Therapeutics, Inc., a clinical-stage pharmaceutical company, develops therapeutics for Parkinson's disease and related disorders. Its lead product candidate is IkT-148009, a small molecule Abelson tyrosine kinase inhibitor, which is in Phase 2a clinical trials to the treatment of Parkinson's disease and gastrointestinal tract. The company is also developing IkT-001Pro, a prodrug of the anticancer agent imatinib mesylate to treat stable phase chronic myelogenous leukemia. Inhibikase Therapeutics, Inc. has research and development collaborations with Johns Hopkins University, Arizona State University, University of Bordeaux, and Michigan State University, as well as University of California; and a collaborative research and development agreement with Sphaera Pharma Pte. Ltd. The company was founded in 2008 and is headquartered in Atlanta, Georgia."

Keywords

The game is changing. There is a new strategy to evaluate Inhibikase Therapeutics fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Inhibikase Therapeutics are: Inhibikase, Therapeutics, year, become, Log, low, high, and the most common words in the summary are: therapeutic, inc, pharmaceutical, pharma, view, bioscience, analyze, . One of the sentences in the summary was: Inhibikase Therapeutics Inc (IKT) Stock Price Today, News, Quotes, FAQs and Fundamentals StockTwits Logo Join the Conversation! Build your trading network Follow your favorite assets Link Your Portfolio and become verified Sign Up Log In Log In to become verified.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #inc #pharmaceutical #pharma #view #bioscience #analyze.

November 15, 2023 1:44 (London Time)